Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial update on bismuth-containing quadruple therapy for Helicobacter pylori eradication is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED